Electronic medication administration records in long‐term care facilities: a scoping review
- Autores: Andrew E.C. Fuller, Lisa M Guirguis, Cheryl A. Sadowski, Mark J. Makowsky
- Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 66, Nº. 7, 1, 2018, págs. 1428-1436
- Idioma: inglés
- Enlaces
-
Resumen
Objectives To map the extent, range, and nature of research on the effectiveness, level of use, and perceptions about electronic medication administration records (eMARs) in long‐term care facilities (LTCFs) and identify gaps in current knowledge and priority areas for future research.
Design Scoping review of quantitative and qualitative literature.
Setting Literature review.
Participants Original research relating to eMAR in LTCF was eligible for inclusion.
Measurements We systematically searched MEDLINE, CINAHL, Scopus, ProQuest, and the Cochrane Library and performed general and advanced searches of Google to identify grey literature. Two authors independently screened for eligibility of studies. Independent reviewers extracted data regarding country of origin, design, study methods, outcomes studied, and main results in duplicate.
Results We identified 694 articles, of which 34 met inclusion criteria. Studies were published between 2006 and 2016 and were mostly from the United States (n=25). Twenty studies (59%) used quantitative methods, including surveys and analysis of eMAR data; 7 (21%) used qualitative methods, including interviews, focus groups, document review, and observation; and 7 (21%) used mixed methods. Three major research areas were explored: medication and medication administration error rates (n=11), eMAR benefits and challenges (n=19), and eMAR prevalence and uptake (n=15). Evidence linking eMAR use and reductions in medication errors is weak because of suboptimal study design and reporting. The majority of studies were descriptive and documented inconsistent benefits and challenges and low levels of eMAR implementation.
Conclusion Further investigation is required to rigorously evaluate the effect of standalone eMAR systems on medication administration errors and patient safety, the extent of eMAR implementation, pharmacists' perceptions, and cost effectiveness of eMAR systems in LTCF.
